HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
26 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TRPM2
transient receptor potential cation channel subfamily M member 2
Chromosome 21 · 21q22.3
NCBI Gene: 7226Ensembl: ENSG00000142185.18HGNC: HGNC:12339UniProt: B4DVI8
169PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Ion ChannelTransporter
RESEARCH IMPACT
Trending
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
hydrolase activityADP-ribose diphosphatase activitymonoatomic cation channel activitycalcium ion bindinganorectal malformationatrial fibrillationneoplasmcancer
✦AI Summary

Unable to provide a comprehensive gene function summary for TRPM2 based on the provided abstracts. The PubMed abstracts supplied exclusively discuss clusterin (CLU), a glycoprotein involved in molecular chaperone function, apoptosis regulation, and disease processes including Alzheimer's disease and cancer. None of these abstracts contain information about TRPM2 (transient receptor potential cation channel subfamily M member 2), its mechanisms, or disease relevance. Based on the UniProt and GO annotations provided (rather than the abstracts), TRPM2 is characterized as a cation channel with ligand-gated calcium channel activity that responds to ADP-ribose and oxidative stress. However, without supporting PubMed evidence, specific mechanistic details, disease associations, and clinical significance cannot be established according to the requirement to ground all claims in provided abstracts. To generate an evidence-based summary of TRPM2 function, abstracts specifically addressing TRPM2 biology, regulation, and disease involvement would be required.

⚠Limited data available — This gene has 0 indexed publications. Summary and analysis may be incomplete.
Disease Associationsⓘ20
anorectal malformationOpen Targets
0.23Weak
atrial fibrillationOpen Targets
0.12Weak
neoplasmOpen Targets
0.11Weak
cancerOpen Targets
0.10Weak
colorectal carcinomaOpen Targets
0.10Suggestive
non-small cell lung carcinomaOpen Targets
0.10Suggestive
gastric cancerOpen Targets
0.09Suggestive
atherosclerosisOpen Targets
0.09Suggestive
breast adenocarcinomaOpen Targets
0.09Suggestive
neuroblastomaOpen Targets
0.09Suggestive
Parkinson diseaseOpen Targets
0.09Suggestive
hepatocellular carcinomaOpen Targets
0.09Suggestive
acute myeloid leukemiaOpen Targets
0.09Suggestive
diabetes mellitusOpen Targets
0.09Suggestive
prostate cancerOpen Targets
0.08Suggestive
ovarian cancerOpen Targets
0.08Suggestive
nonpapillary renal cell carcinomaOpen Targets
0.08Suggestive
Behcet's syndromeOpen Targets
0.08Suggestive
retinoblastomaOpen Targets
0.08Suggestive
endometrial cancerOpen Targets
0.07Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
TRPM7Protein interaction98%TRPV2Protein interaction96%STIM1Protein interaction73%ORAI1Protein interaction70%TRPV1Protein interaction56%RYR3Shared pathway28%
Tissue Expression6 tissues
Bone Marrow
100%
Brain
9%
Lung
7%
Liver
3%
Heart
2%
Ovary
2%
Gene Interaction Network
Click a node to explore
TRPM2TRPM7TRPV2STIM1ORAI1TRPV1RYR3
PROTEIN STRUCTURE
Preparing viewer…
PDB8E6U · 3.20 Å · EM
View on RCSB ↗
Constraintⓘ
LOEUFⓘ
1.05LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.92 [0.81–1.05]
RankingsWhere TRPM2 stands among ~20K protein-coding genes
  • #2,637of 20,598
    Most Researched169 · top quartile
  • #10,454of 17,882
    Most Constrained (LOEUF)1.05
Genes detectedTRPM2
Sources retrieved26 papers
Response time—
📄 Sources
26▼
1
Clusterin: structure, function and roles in disease.
PMID: 39991767
Int J Med Sci · 2025
1.00
2
Clusterin.
PMID: 11906815
Int J Biochem Cell Biol · 2002
0.90
3
Clusterin and chemoresistance.
PMID: 19879424
Adv Cancer Res · 2009
0.80
4
Structural analyses define the molecular basis of clusterin chaperone function.
PMID: 40781479
Nat Struct Mol Biol · 2025
0.70
5
Clusterin: Always protecting. Synthesis, function and potential issues.
PMID: 33360046
Biomed Pharmacother · 2021
0.64